When to Look for Von Hippel-Lindau Disease in Gastroenteropancreatic Neuroendocrine Tumors?

Von Hippel-Lindau (VHL) disease is a progressive autosomal dominant multisystem disorder that is associated with a germ line mutation of the VHL gene on the short arm of chromosome 3. A variety of benign and malignant diseases, including eye and CNS hemangioblastomas, renal cell carcinoma and pheochromocytoma are the major components. Gastroenteropancreatic neuroendocrine tumors are also listed among the typical complications, although these occur seldom. Virtually all such tumors are pancreatic islet cell tumors. VHL-associated islet cell tumors are mostly hormone-inactive. They can be detected during screening investigations according to the multidisciplinary disorder or by workup of space-occupying lesions. There are no specific predictors for malignancy in VHL-associated islet cell neoplasias, but tumors smaller than 3 cm in diameter are believed to be always benign. Gadolinium-enhanced MRI is currently the imaging method of choice, but contrast-enhanced CT is also a diagnostic option. The spectrum of manifestations is illustrated by selected cases.

[1]  P. E. V. Hippel.  Die anatomische Grundlage der von mir beschriebenen „sehr seltenen Erkrankung der Netzhaut“ , 1911, Albrecht von Graefes Archiv für Ophthalmologie.

[2]  P. E. V. Hippel.  Über eine sehr seltene Erkrankung der Netzhaut , 1904, Albrecht von Graefes Archiv für Ophthalmologie.

[3]  P. Tauzin-Fin,et al.  Laparoscopic surgery for pheochromocytoma. , 2004, European urology.

[4]  G. Doherty.  Multiple endocrine neoplasia type 1: duodenopancreatic tumors. , 2003, Surgical oncology.

[5]  J. Strauchen.  Germ-line mutations in nonsyndromic pheochromocytoma. , 2002, The New England journal of medicine.

[6]  H. Neumann,et al.  Endoscopic Treatment of Solitary, Bilateral, Multiple, and Recurrent Pheochromocytomas and Paragangliomas , 2002, World Journal of Surgery.

[7]  J. Schipper,et al.  Germ-line mutations in nonsyndromic pheochromocytoma. , 2002, The New England journal of medicine.

[8]  C. Nies,et al.  Predictive Genetic Screening and Clinical Findings in Multiple Endocrine Neoplasia Type I Families , 2001, World Journal of Surgery.

[9]  F. Collins,et al.  A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[10]  H. Neumann,et al.  Long-term results of laser treatment for retinal angiomatosis in von Hippel-Lindau disease. , 2000, European journal of medical research.

[11]  A. Dackiw,et al.  Screening for MEN1 mutations in patients with atypical endocrine neoplasia. , 1999, Surgery.

[12]  H. Neumann,et al.  Preserved adrenocortical function after laparoscopic bilateral adrenal sparing surgery for hereditary pheochromocytoma. , 1999, The Journal of clinical endocrinology and metabolism.

[13]  T. Henn,et al.  Cytogenetic and CGH studies of four neuroendocrine tumors and tumor-derived cell lines of a patient with multiple endocrine neoplasia type 1. , 1999, International journal of oncology.

[14]  N. Hatano,et al.  Pancreatic metastasis from renal cell carcinoma causing massive gastrointestinal bleeding in von Hippel-Lindau disease. , 1999, Hepato-gastroenterology.

[15]  H. Neumann,et al.  Adrenal‐sparing surgery for phaeochromocytoma , 1999, The British journal of surgery.

[16]  L. Koulischer,et al.  Mutation analysis of the MEN1 gene in Belgian patients with multiple endocrine neoplasia type 1 and related diseases , 1999, Human mutation.

[17]  J. Mulvihill,et al.  The variable penetrance and spectrum of manifestations of multiple endocrine neoplasia type 1. , 1998, Surgery.

[18]  H. Brauch,et al.  Prevalence, morphology and biology of renal cell carcinoma in von Hippel-Lindau disease compared to sporadic renal cell carcinoma. , 1998, The Journal of urology.

[19]  G. Bartsch,et al.  Laparoscopic surgery for pheochromocytoma: adrenalectomy, partial resection, excision of paragangliomas. , 1998, The Journal of urology.

[20]  S. Forbes,et al.  Characterization of mutations in patients with multiple endocrine neoplasia type 1. , 1998, American journal of human genetics.

[21]  W. Linehan,et al.  Improved detection of germline mutations in the von Hippel‐Lindau disease tumor suppressor gene , 1998, Human mutation.

[22]  F. Collins,et al.  Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states. , 1997, Human molecular genetics.

[23]  D. Miller,et al.  Islet cell tumors of the pancreas: clinical, radiologic, and pathologic correlation in diagnosis and localization. , 1997, Radiographics : a review publication of the Radiological Society of North America, Inc.

[24]  C. Su,et al.  Management of Pancreatic Lesions in von Hippel-Lindau Disease , 1997, World Journal of Surgery.

[25]  B. Zbar,et al.  Renal cysts, renal cancer and von Hippel-Lindau disease. , 1997, Kidney international.

[26]  E. Fishman,et al.  Pancreatic metastases from renal cell carcinoma in von Hippel-Lindau disease. , 1997, Clinical imaging.

[27]  C. Edwards,et al.  Clinical studies of multiple endocrine neoplasia type 1 (MEN1) , 1996, QJM : monthly journal of the Association of Physicians.

[28]  D. Hough,et al.  Pancreatic lesions in von Hippel-Lindau disease: prevalence, clinical significance, and CT findings. , 1994, AJR. American journal of roentgenology.

[29]  H. Neumann,et al.  Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease. , 1993, The New England journal of medicine.

[30]  J. Gnarra,et al.  Identification of the von Hippel-Lindau disease tumor suppressor gene. , 1993, Science.

[31]  J. Maertens,et al.  Common bile duct obstruction due to pancreatic involvement in the von Hippel-Lindau syndrome. , 1992, The American journal of gastroenterology.

[32]  H. Brambs,et al.  Pancreatic lesions in the von Hippel-Lindau syndrome. , 1991, Gastroenterology.

[33]  C. Johnson,et al.  Islet cell tumors in von Hippel-Lindau disease: increased prevalence and relationship to the multiple endocrine neoplasias. , 1990, AJR. American journal of roentgenology.

[34]  P. Choyke,et al.  von Hippel-Lindau disease: radiologic screening for visceral manifestations. , 1990, Radiology.

[35]  Y. Hsia,et al.  Von Hippel‐Lindau Disease Affecting 43 Members of a Single Kindred , 1989, Medicine.

[36]  Hsia Ye,et al.  von Hippel-Lindau disease affecting 43 members of a single kindred. , 1989 .

[37]  H. Neumann.  Basic criteria for clinical diagnosis and genetic counselling in von Hippel-Lindau syndrome. , 1987, VASA. Zeitschrift fur Gefasskrankheiten.

[38]  J. Coombs,et al.  Metastatic islet cell tumor in von Hippel-Lindau disease. , 1984, The American journal of medicine.

[39]  W. Alberts,et al.  Mixed multiple endocrine neoplasia syndromes. , 1980, JAMA.

[40]  A. Kees.  [Malignant carcinoid and phaeochromocytoma in von-Hippel-Lindau's disease--a case report (author's transl)]. , 1980, Wiener Klinische Wochenschrift.

[41]  M. T. Hull,et al.  Familial islet cell tumors in von Hippel‐Lindau's disease , 1979, Cancer.

[42]  Fishman Rs,et al.  Severe pancreatic involvement in three generations in von Hippel-Lindau disease. , 1979 .

[43]  L. G. Bartholomew,et al.  Severe pancreatic involvement in three generations in von Hippel-Lindau disease. , 1979, Mayo Clinic proceedings.

[44]  A. Lindau.  Studien Uber Kleinhirncysten. Bau, Pathogenese und Beziehungen zur Angiomatosis Retinae , 1926 .